Neonatal screening for inborn errors of metabolism: update

Area of Science:

• Medical Genetics
• Pediatrics
• Metabolic Disorders

Background:

• Newborn screening for inborn errors of metabolism is a proven public health strategy.
• Early detection prevents severe morbidity, mortality, and intellectual disability in affected children.
• The American Academy of Pediatrics advocates for universal screening for conditions like PKU and hypothyroidism.

Purpose of the Study:

• To highlight the established value of newborn screening for metabolic disorders.
• To emphasize the need for integrated programs encompassing screening, diagnosis, management, and support.
• To address the ongoing challenges in maintaining and advancing newborn screening programs.

Main Methods:

• Review of established newborn screening practices.
• Analysis of the impact of screening on child health outcomes.
• Discussion of recommendations from the American Academy of Pediatrics.

Main Results:

• Newborn screening effectively prevents severe health consequences of inherited metabolic disorders.
• Integrated care models are essential for maximizing the benefits of screening.
• Continuous improvement and development of screening and follow-up are necessary.

Conclusions:

• Newborn screening is vital for preventing serious health issues in infants.
• Comprehensive, integrated programs are essential for optimal child health outcomes.
• Addressing 21st-century challenges is key to ensuring the future success of newborn screening.